Skip to main content

LINCOLN NATIONAL CORP

For the period ended Mar 31, 2025. Filed May 8, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 8, 2025

LNC$40.05+2.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Consolidated Balance Sheets as of (Unaudited) and December 31,

CONSOLIDATED BALANCE SHEETS

(in millions, except share data)

As ofAs of
March 31,December 31,
20252024
(Unaudited)
ASSETS
Investments:
Fixed maturity available-for-sale securities, at fair value
(amortized cost: 2025 - $97,795; 2024 - $97,415; allowance for credit losses: 2025 - $74; 2024 - $46)$88,297$87,111
Trading securities1,9842,025
Equity securities345294
Mortgage loans on real estate, net of allowance for credit losses
(portion at fair value: 2025 - $232; 2024 - $232)21,55821,083
Policy loans2,5292,476
Derivative investments7,8499,677
Other investments6,6536,588
Total investments129,215129,254
Cash and invested cash4,2845,801
Deferred acquisition costs, value of business acquired and deferred sales inducements12,56312,537
Reinsurance recoverables, net of allowance for credit losses28,58028,750
Deposit assets, net of allowance for credit losses31,04830,776
Market risk benefit assets4,1574,860
Accrued investment income1,1341,108
Goodwill1,1441,144
Other assets8,2678,163
Separate account assets162,506168,438
Total assets$382,898$390,831
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities
Policyholder account balances$125,262$126,197
Future contract benefits40,66539,807
Funds withheld reinsurance liabilities16,83816,907
Market risk benefit liabilities1,3061,046
Deferred front-end loads6,9106,730
Payables for collateral on investments8,28210,020
Short-term debt–300
Long-term debt5,8685,856
Other liabilities7,0687,261
Separate account liabilities162,506168,438
Total liabilities374,705382,562
Contingencies and Commitments (See Note 13)
Stockholders’ Equity
Preferred stock – 10,000,000 shares authorized:
Series C preferred stock – 20,000 shares authorized, issued and outstanding
as of March 31, 2025, and December 31, 2024493493
Series D preferred stock – 20,000 shares authorized, issued and outstanding
as of March 31, 2025, and December 31, 2024493493
Common stock – 800,000,000 shares authorized; 170,695,166 and 170,380,646 shares
issued and outstanding as of March 31, 2025, and December 31, 2024, respectively4,7034,674
Retained earnings6,8107,645
Accumulated other comprehensive income (loss)(4,306)(5,036)
Total stockholders’ equity8,1938,269
Total liabilities and stockholders’ equity$382,898$390,831
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.